person · Reporting owner
Leimkuhler William F.
Disclosed activity across 3 companies
Sign in to followReported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| ARGAN INCAGX · Entity 3828 | Director | June 10, 2026 | June 12, 2026 |
| Elite Health Systems Inc.EHSI · Entity 7531 | Director | August 06, 2025 | August 08, 2025 |
| Northern Power Systems Corp.NPS · Entity 164185 | Director | May 25, 2017 | May 30, 2017 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
ARGAN INC
Report date June 10, 2026 · Filed June 12, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 37,028 |
Reported balance
After 2026-06-10 transaction · row 1
1 source rowRow 1 · 2026-06-10 · Exercise / conversion · Acquired 533 · Balance 37,028 F1: Pursuant to the one-year vesting schedule of the Time-Based Restricted Stock Units ("TRSUs") awarded to the Reporting Person on June 17, 2025, 530 shares of the Issuer's common stock became issuable to the Reporting Person on June 10, 2026 and is adjusted for dividends. |
| Time-Based Restricted Stock UnitsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | 834 |
Reported balance
After 2026-06-10 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2026-06-10 · Exercise / conversion · Disposed 530 · Balance 834 F1: Pursuant to the one-year vesting schedule of the Time-Based Restricted Stock Units ("TRSUs") awarded to the Reporting Person on June 17, 2025, 530 shares of the Issuer's common stock became issuable to the Reporting Person on June 10, 2026 and is adjusted for dividends. |
| Time-Based Restricted Stock UnitsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | 1,023 |
Reported balance
After 2026-06-10 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2026-06-10 · Grant · Acquired 189 · Balance 1,023 F2: On June 10, 2026 the Reporting Person was granted TRSUs covering 189 shares of the Issuer's common stock. The TRSUs will vest fully on June 10, 2027 or on the date of the 2027 Annual Meeting of Stockholders, whichever comes first. |
| Common StockSEC Table I · non-derivative | IndirectSelf as Trustee for Elizabeth K Leimkuhler Trust | 500 |
Reported balance
Holding disclosure · report date 2026-06-10 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 500 |
| Common StockSEC Table I · non-derivative | IndirectSelf as Trustee for Emily K Leimkuhler Trust | 500 |
Reported balance
Holding disclosure · report date 2026-06-10 · row 3
Holding and transaction disclosures are not merged.
1 source rowRow 3 · Balance 500 |
Filing footnotes · ownership attribution and instrument terms
F1: Pursuant to the one-year vesting schedule of the Time-Based Restricted Stock Units ("TRSUs") awarded to the Reporting Person on June 17, 2025, 530 shares of the Issuer's common stock became issuable to the Reporting Person on June 10, 2026 and is adjusted for dividends.
F2: On June 10, 2026 the Reporting Person was granted TRSUs covering 189 shares of the Issuer's common stock. The TRSUs will vest fully on June 10, 2027 or on the date of the 2027 Annual Meeting of Stockholders, whichever comes first.
Elite Health Systems Inc.
Report date August 06, 2025 · Filed August 08, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 265,000 |
Reported balance
After 2025-08-06 transaction · row 1
1 source rowRow 1 · 2025-08-06 · Grant · Acquired 40,000 · Balance 265,000 |
| 2025 Equity Incentive PlanSEC Table II · derivative / convertible security · Conversion / exercise price $0.95 · Expires 2035-08-06 | Direct | 25,000 |
Reported balance
After 2025-08-06 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2025-08-06 · Grant · Acquired 25,000 · Balance 25,000 F1: NA |
Filing footnotes · ownership attribution and instrument terms
F1: NA
Northern Power Systems Corp.
Report date May 25, 2017 · Filed May 30, 2017
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common SharesSEC Table I · non-derivative | Direct | 148,441 |
Reported balance
After 2017-05-25 transaction · row 1
1 source rowRow 1 · 2017-05-25 · Grant · Acquired 30,000 · Balance 148,441 F1: Each restricted stock unit represents a contingent right to receive one share of NPS common stock. The grant represents an annual grant of restricted stock units to non-executive directors under the Northern Power Systems Corp. 2014 Stock Option and Incentive Plan. 25% of the shares vest upon grant and the remaining 75% vest in equal installments over the subsequent 3 quarters. |
| Common SharesSEC Table I · non-derivative | IndirectBy Simplified Employee Pension IRA | 10,000 |
Reported balance
Holding disclosure · report date 2017-05-25 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 10,000 |
Filing footnotes · ownership attribution and instrument terms
F1: Each restricted stock unit represents a contingent right to receive one share of NPS common stock. The grant represents an annual grant of restricted stock units to non-executive directors under the Northern Power Systems Corp. 2014 Stock Option and Incentive Plan. 25% of the shares vest upon grant and the remaining 75% vest in equal installments over the subsequent 3 quarters.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 14, 2024 Filed Jun 18, 2024 13:15 UTC | ARGAN INC AGX · Entity 3828 | Exercise / conversionCommon Stock | 5,852 | $31.82 | $186,210.64 |
DisclosureSEC source: 0001415889-24-017317 · form4-06182024_090602.xml · nonDerivative · entry 1 Leimkuhler William F. · CIK 0001361943 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 45,852 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: On June 14, 2024, the Reporting Person exercised his option awarded on December 11, 2014 to purchase 10,000 shares of the Issuer's common stock at a price of $31.82 per share, using the net settle approach. Read SEC document |
| December 14, 2023 Filed Dec 18, 2023 23:40 UTC | ARGAN INC AGX · Entity 3828 | GrantTime-Based Restricted Stock Units · Derivative | 2,500 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001415889-23-016659 · form4-12182023_111201.xml · derivative · entry 2 Leimkuhler William F. · CIK 0001361943 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,000 Underlying: Common Stock · 2,500 shares Expires 2026-12-14 F2 · shares: On December 14, 2023, the Reporting Person was granted Time-Based Restricted Stock Units ("TRSUs") covering 2,500 shares of common stock. The TRSUs will vest in equal installments on each of the next three anniversaries of the grant date starting on 12/14/2024. Read SEC document |
| December 14, 2023 Filed Dec 18, 2023 23:40 UTC | ARGAN INC AGX · Entity 3828 | GrantOption to Purchase Common Stock · Derivative | 1,500 | $0.00 Strike: $43.70 | $0.00 |
DisclosureSEC source: 0001415889-23-016659 · form4-12182023_111201.xml · derivative · entry 1 Leimkuhler William F. · CIK 0001361943 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 81,500 Underlying: Common Stock · 1,500 shares Expires 2033-12-14 F1 · shares: On December 14, 2023, the Reporting Person received 10-year options to purchase 1,500 shares of the Issuer's common stock with an exercise price of $43.70 per share. The options will vest ratably over three years on each anniversary of the grant date starting from 12/14/2024. Read SEC document |
| June 14, 2023 Filed Jun 20, 2023 20:30 UTC | ARGAN INC AGX · Entity 3828 | Exercise / conversionOption to Purchase Common Stock · Derivative | 10,000 | $0.00 Strike: $26.88 | $0.00 |
DisclosureSEC source: 0001415889-23-010052 · form4-06202023_040601.xml · derivative · entry 4 Leimkuhler William F. · CIK 0001361943 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 80,000 Underlying: Common Stock · 10,000 shares Expires 2023-12-17 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 14, 2023 Filed Jun 20, 2023 20:30 UTC | ARGAN INC AGX · Entity 3828 | Exercise / conversionCommon Stock | 10,000 | $26.88 | $268,800.00 |
DisclosureSEC source: 0001415889-23-010052 · form4-06202023_040601.xml · nonDerivative · entry 1 Leimkuhler William F. · CIK 0001361943 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 40,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: On June 14, 2023 the Reporting Person exercised his stock option received on December 17, 2013 to purchase 10,000 shares of the Issuer's common stock at a price of $26.88 per share. Read SEC document |
| December 16, 2022 Filed Dec 20, 2022 21:15 UTC | ARGAN INC AGX · Entity 3828 | GrantTime-Based Restricted Stock Units · Derivative | 1,750 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001415889-22-012850 · form4-12202022_041234.xml · derivative · entry 2 Leimkuhler William F. · CIK 0001361943 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,500 Underlying: Common Stock · 1,750 shares Expires 2025-12-16 F4 · shares: On December 16, 2022, the Reporting Person was granted Time-Based Restricted Stock Units (the "TBRSUs") covering 1,750 shares of common stock. The TBRSUs will vest in their entirety on the third anniversary of the grant date on 12/16/2025. F5 · balance_after: (g) 10,000 shares of common stock at a price of $40.15 with initial Date Exercisable of 12/23/2020 and an Expiration Date of 12/23/2029; (h) 10,000 shares of common stock at a price of $45.75 per share with initial Date Exercisable of 12/14/2021 and Expiration Date of 12/14/2030; (i) 5,000 shares of common stock at a price of $37.13 per share with initial Date Exercisable of 12/14/2022 and Expiration Date of 12/14/203; and (j) 5,000 shares of common stock at a price of $35.72 per share with initial Date Exercisable of 12/16/2023 and Expiration Date of 12/16/2032. All stock options are subject to the aforementioned three-year ratable vesting schedule except those awarded prior to January 2018 which vested fully on the first anniversary of the date of award. Read SEC document |
| December 16, 2022 Filed Dec 20, 2022 21:15 UTC | ARGAN INC AGX · Entity 3828 | GrantOption to Purchase Common Stock · Derivative | 5,000 | $0.00 Strike: $35.72 | $0.00 |
DisclosureSEC source: 0001415889-22-012850 · form4-12202022_041234.xml · derivative · entry 1 Leimkuhler William F. · CIK 0001361943 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 90,000 Underlying: Common Stock · 5,000 shares Expires 2032-12-16 F1 · shares: On December 16, 2022, the Reporting Person received 10-year options to purchase 5,000 shares of the Issuer's Common Stock at an exercise price of $35.72 per share. The options will vest ratably over three years on each anniversary of the grant date beginning on 12/16/2023. F2 · balance_after: As of the date of this filing, the Reporting Person owns options to purchase (a) 10,000 shares of Common Stock at a price of $26.88 per share with initial Date Exercisable of 12/17/2014 and Expiration Date of 12/17/2023; (b) 10,000 shares of Common Stock at a price of $31.82 per share with initial Date Exercisable of 12/11/2015 and Expiration Date of 12/11/2024; (c) 10,000 shares of Common Stock at a price of $30.44 per share with initial Date Exercisable of 1/7/2017 and Expiration Date of 1/7/2026; (d) 10,000 shares of common stock at a price of $71.75 per share with initial Date Exercisable of 1/5/2018 and Expiration Date of 1/5/2027; (e) 10,000 shares of common stock at a price of $46.35 per share with initial Date Exercisable of 1/11/2019 and Expiration Date of 1/11/2028; (f) 10,000 shares of common stock at a price of $41.19 per share with initial Date Exercisable of 12/12/2019 and Expiration Date of 12/12/2028; F3 · balance_after: (g) 10,000 shares of common stock at a price of $40.15 with initial Date Exercisable of 12/23/2020 and an Expiration Date of 12/23/2029; (h) 10,000 shares of common stock at a price of $45.75 per share with initial Date Exercisable of 12/14/2021 and Expiration Date of 12/14/2030; (i) 5,000 shares of common stock at a price of $37.13 per share with initial Date Exercisable of 12/14/2022 and Expiration Date of 12/14/203; and (j) 5,000 shares of common stock at a price of $35.72 per share with initial Date Exercisable of 12/16/2023 and Expiration Date of 12/16/2032. All stock options are subject to the aforementioned three-year ratable vesting schedule except those awarded prior to January 2018 which vested fully on the first anniversary of the date of award. Read SEC document |
| September 26, 2022 Filed Sep 26, 2022 23:17 UTC | Elite Health Systems Inc. USNU · Entity 7531 | GrantCommon Stock | 50,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001361943-22-000001 · primary_doc.xml · nonDerivative · entry 1 Leimkuhler William F. · CIK 0001361943 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 150,000 F1 · price: Effective September 26, 2022, the Issuer granted to the Reporting Person 50,000 shares of the Issuer's Common Stock, fully vested as of the date of grant, for past and future services as a director. Read SEC document |
| December 14, 2021 Filed Dec 16, 2021 21:15 UTC | ARGAN INC AGX · Entity 3828 | GrantTime-Based Restricted Stock Units · Derivative | 1,750 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001415889-21-006029 · form4-12162021_041225.xml · derivative · entry 5 Leimkuhler William F. · CIK 0001361943 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,750 Underlying: Common Stock · 1,750 shares Expires 2024-12-14 F4 · shares: On December 14, 2021, the Reporting Person was granted Time-Based Restricted Stock Units (the "TBRSUs") covering 1,750 shares of common stock. The TBRSUs will vest in their entirety on the third anniversary of the grant date on 12/14/2024. Read SEC document |
| December 14, 2021 Filed Dec 16, 2021 21:15 UTC | ARGAN INC AGX · Entity 3828 | GrantOption to Purchase Common Stock · Derivative | 5,000 | $0.00 Strike: $37.13 | $0.00 |
DisclosureSEC source: 0001415889-21-006029 · form4-12162021_041225.xml · derivative · entry 4 Leimkuhler William F. · CIK 0001361943 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 85,000 Underlying: Common Stock · 5,000 shares Expires 2031-12-14 F1 · shares: On December 14, 2021, the Reporting Person received 10-year options to purchase 5,000 shares of the Issuer's Common Stock at an exercise price of $37.13 per share. The options will vest ratably over three years on each anniversary of the grant date beginning on 12/14/2022 F2 · balance_after: As of the date of this filing, the Reporting Person owns options to purchase (a) 10,000 shares of Common Stock at a price of $26.88 per share with initial Date Exercisable of 12/17/2014 and Expiration Date of 12/17/2023; (b) 10,000 shares of Common Stock at a price of $31.82 per share with initial Date Exercisable of 12/11/2015 and Expiration Date of 12/11/2024; (c) 10,000 shares of Common Stock at a price of $30.44 per share with initial Date Exercisable of 1/7/2017 and Expiration Date of 1/7/2026; (d) 10,000 shares of common stock at a price of $71.75 per share with initial Date Exercisable of 1/5/2018 and Expiration Date of 1/5/2027; (e) 10,000 shares of common stock at a price of $46.35 per share with initial Date Exercisable of 1/11/2019 and Expiration Date of 1/11/2028; (f) 10,000 shares of common stock at a price of $41.19 per share with initial Date Exercisable of 12/12/2019 and Expiration Date of 12/12/2028; F3 · balance_after: (g) 10,000 shares of common stock at a price of $40.15 with initial Date Exercisable of 12/23/2020 and an Expiration Date of 12/23/2029; (h) 10,000 shares of common stock at a price of $45.75 per share with initial Date Exercisable of 12/14/2021 and Expiration Date of 12/14/2030; and (i) 5,000 shares of common stock at a price of $37.13 per share with initial Date Exercisable of 12/14/2022 and Expiration Date of 12/14/2031. All stock options are subject to the aforementioned three-year ratable vesting schedule except those awarded prior to January 2018 which vested fully on the first anniversary of the date of award. Read SEC document |
| December 14, 2020 Filed Dec 16, 2020 21:16 UTC | ARGAN INC AGX · Entity 3828 | GrantStock Option to Purchase Common Stock · Derivative | 10,000 | $0.00 Strike: $45.75 | $0.00 |
DisclosureSEC source: 0001104659-20-136293 · tm2038593-2_4seq1.xml · derivative · entry 4 Leimkuhler William F. · CIK 0001361943 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 80,000 Underlying: Common Stock · 10,000 shares Expires 2030-12-14 F1 · shares: On December 14, 2020, the Reporting Person received 10-year options to purchase 10,000 shares of the Issuer's common stock with an exercise price of $45.75 per share. The options will vest ratably over three years on each anniversary of the grant date beginning 12/14/2021. F2 · balance_after: As of the date of this filing, the Reporting Person owns options to purchase (a) 10,000 shares of Common Stock at a price of $26.88 per share with initial Date Exercisable of 12/17/2014 and Expiration Date of 12/17/2023; (b) 10,000 shares of Common Stock at a price of $31.82 per share with initial Date Exercisable of 12/11/2015 and Expiration Date of 12/11/2024; (c) 10,000 shares of Common Stock at a price of $30.44 per share with initial Date Exercisable of 1/7/2017 and Expiration Date of 1/7/2026; (d) 10,000 shares of common stock at a price of $71.75 per share with initial Date Exercisable of 1/5/2018 and Expiration Date of 1/5/2027; F3 · balance_after: (e) 10,000 shares of common stock at a price of $46.35 per share with initial Date Exercisable of 1/11/2019 and Expiration Date of 1/11/2028; (f) 10,000 shares of common stock at a price of $41.19 per share with initial Date Exercisable of 12/12/2019 and Expiration Date of 12/12/2028; (g) 10,000 shares of common stock at a price of $40.15 with initial Date Exercisable of 12/23/2020 and an Expiration Date of 12/23/2029; and (h) 10,000 shares of common stock at a price of $45.75 per share with initial Date Exercisable of 12/14/2021 and Expiration Date of 12/14/2030, all of which are subject to the aforementioned three-year ratably vesting schedule. Read SEC document |
| July 20, 2020 Filed Jul 21, 2020 20:01 UTC | ARGAN INC AGX · Entity 3828 | Exercise / conversionStock Option to Purchase Common Stock · Derivative | 10,000 | $0.00 Strike: $18.87 | $0.00 |
DisclosureSEC source: 0001104659-20-085263 · a4.xml · derivative · entry 4 Leimkuhler William F. · CIK 0001361943 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 70,000 Underlying: Common Stock · 10,000 shares Expires 2022-12-18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: On July 20, 2020, the Reporting Person exercised his stock option to purchase 10,000 shares of the Issuer's common stock at a price of $18.87 per share. F1 · derivative.underlying_shares: On July 20, 2020, the Reporting Person exercised his stock option to purchase 10,000 shares of the Issuer's common stock at a price of $18.87 per share. F2 · balance_after: The total number of stock options owned by the Reporting Person includes options to acquire; (a) 10,000 shares of Common Stock at an Exercise Price of $26.88 per share with Date Exercisable of 12/17/2014 and Expiration Date of 12/17/2023; (b) 10,000 shares of Common Stock at an Exercise Price of $31.82 per share with Date Exercisable of 12/11/2015 and Expiration Date of 12/11/2024; (c) 10,000 shares of Common Stock at an Exercise Price of $30.44 per share with Date Exercisable of 1/7/2017 and Expiration Date of 1/7/2026; (d) 10,000 shares of common stock at a price of $71.75 per share with Date Exercisable of 1/5/2018 and Expiration Date of 1/5/2027; F3 · balance_after: (e) 10,000 shares of common stock at a price of $46.35 per share with initial Date Exercisable of 1/11/2019 and Expiration Date of 1/11/2028; (f) 10,000 shares of common stock at a purchase price of $41.19 per share with initial Date Exercisable beginning on 12/12/2019 and Expiration Date of 12/12/2028; and (g) 10,000 shares of common stock at a price of $40.15 per share with initial Date Exercisable of 12/23/2020 and an Expiration Date of 12/23/2029. Read SEC document |
| July 20, 2020 Filed Jul 21, 2020 20:01 UTC | ARGAN INC AGX · Entity 3828 | Exercise / conversionCommon Stock | 10,000 | $18.87 | $188,700.00 |
DisclosureSEC source: 0001104659-20-085263 · a4.xml · nonDerivative · entry 1 Leimkuhler William F. · CIK 0001361943 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: On July 20, 2020, the Reporting Person exercised his stock option to purchase 10,000 shares of the Issuer's common stock at a price of $18.87 per share. Read SEC document |
| December 23, 2019 Filed Dec 26, 2019 16:10 UTC | ARGAN INC AGX · Entity 3828 | GrantStock Option to Purchase Common Stock · Derivative | 10,000 | $0.00 Strike: $40.15 | $0.00 |
DisclosureSEC source: 0001104659-19-075966 · a4.xml · derivative · entry 4 Leimkuhler William F. · CIK 0001361943 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 80,000 Underlying: Common Stock · 10,000 shares Expires 2029-12-23 F1 · shares: On December 23, 2019 (the "Grant Date"), the Reporting Person received 10-year options, vesting ratably over three years on each anniversary date from the Grant Date, to purchase 10,000 shares of the Issuer's common stock with an exercise price of $40.15 per share. F2 · balance_after: The total number of stock options owned by the Reporting Person includes options to acquire (a) 10,000 shares of Common Stock at an Exercise Price of $18.87 per share with Date Exercisable of 12/18/2013 and Expiration Date of 12/18/2022; (b) 10,000 shares of Common Stock at an Exercise Price of $26.88 per share with Date Exercisable of 12/17/2014 and Expiration Date of 12/17/2023; (c) 10,000 shares of Common Stock at an Exercise Price of $31.82 per share with Date Exercisable of 12/11/2015 and Expiration Date of 12/11/2024; (d) 10,000 shares of Common Stock at an Exercise Price of $30.44 per share with Date Exercisable of 1/7/2017 and Expiration Date of 1/7/2026; (e) 10,000 shares of common stock at a price of $71.75 per share with Date Exercisable of 1/5/2018 and Expiration Date of 1/5/2027; F3 · balance_after: (f) 10,000 shares of common stock at a price of $46.35 per share with initial Date Exercisable of 1/11/2019 and Expiration Date of 1/11/2028; (g) 10,000 shares of common stock at a purchase price of $41.19 per share with initial Date Exercisable beginning on 12/12/2019 and Expiration Date of 12/12/2028; and (h) 10,000 shares of common stock at a price of $40.15 per share with initial Date Exercisable of 12/23/2020 and an Expiration Date of 12/23/2029. Read SEC document |
| December 12, 2019 Filed Dec 14, 2018 00:25 UTC | ARGAN INC AGX · Entity 3828 | GrantStock Option to purchase Common Stock · Derivative | 10,000 | $0.00 Strike: $41.19 | $0.00 |
DisclosureSEC source: 0001104659-18-072876 · a4.xml · derivative · entry 4 Leimkuhler William F. · CIK 0001361943 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 70,000 Underlying: Common Stock · 10,000 shares Expires 2028-12-12 F1 · shares: On December 12, 2018 (the "Grant Date"), the Reporting Person received 10-year options, vesting ratably over three years on each anniversary date from the Grant Date, to purchase 10,000 shares of the Issuer's common stock with an exercise price of $41.19 per share. F2 · balance_after: The total number of stock options owned by the Reporting Person includes options to acquire (i) 10,000 shares of Common Stock at an Exercise Price of $18.87 per share with Date Exercisable of 12/18/2013 and Expiration Date of 12/18/2022; (ii) 10,000 shares of Common Stock at an Exercise Price of $26.88 per share with Date Exercisable of 12/17/2014 and Expiration Date of 12/17/2023; (iii) 10,000 shares of Common Stock at an Exercise Price of $31.82 per share with Date Exercisable of 12/11/2015 and Expiration Date of 12/11/2024; (iv) 10,000 shares of Common Stock at an Exercise Price of $30.44 per share with Date Exercisable of 1/7/2017 and Expiration Date of 1/7/2026; F3 · balance_after: (v) 10,000 shares of common stock at a price of $71.75 per share with Date Exercisable of 1/5/2018 and Expiration Date of 1/5/2027; (vi) 10,000 shares of common stock at a price of $46.35 per share with Date Exercisable of 1/11/2019 and Expiration Date of 1/11/2028; and (vii) 10,000 shares of common stock at a purchase price of $41.19 per share with initial Date Exercisable beginning on 12/12/2019 and Expiration Date of 12/12/2028. Read SEC document |
| January 11, 2018 Filed Jan 13, 2018 00:59 UTC | ARGAN INC AGX · Entity 3828 | GrantStock Option to purchase Common Stock · Derivative | 10,000 | $0.00 Strike: $46.35 | $0.00 |
DisclosureSEC source: 0001104659-18-002134 · a4.xml · derivative · entry 4 Leimkuhler William F. · CIK 0001361943 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,000 Underlying: Common Stock · 10,000 shares Expires 2028-01-11 F1 · shares: On January 11, 2018 (the "Grant Date"), the Reporting Person received 10-year options, vesting ratably over three years on each anniversary date from the Grant Date, to purchase 10,000 shares of the Issuer's common stock with an exercise price of $46.35 per share. F2 · balance_after: The total number of stock options owned by the Reporting Person includes options to acquire (i) 10,000 shares of Common Stock at an Exercise Price of $18.87 per share with Date Exercisable of 12/18/2013 and Expiration Date of 12/18/2022; (ii) 10,000 shares of Common Stock at an Exercise Price of $26.88 per share with Date Exercisable of 12/17/2014 and Expiration Date of 12/17/2023; (iii) 10,000 shares of Common Stock at an Exercise Price of $31.82 per share with Date Exercisable of 12/11/2015 and Expiration Date of 12/11/2024; (iv) 10,000 shares of Common Stock at an Exercise Price of $30.44 per share with Date Exercisable of 1/7/2017 and Expiration Date of 1/7/2026; (v) 10,000 shares of common stock at a price of $71.75 per share with Date Exercisable of 1/5/2018 and Expiration Date of 1/5/2027; and (vi) 10,000 shares of common stock at a price of $46.35 per share with Date Exercisable of 1/11/2019 and Expiration Date of 1/11/2028. Read SEC document |
| December 12, 2017 Filed Dec 13, 2017 21:23 UTC | ARGAN INC AGX · Entity 3828 | Exercise / conversionStock Option to purchase Common Stock · Derivative | 5,000 | $0.00 Strike: $17.33 | $0.00 |
DisclosureSEC source: 0001104659-17-073151 · a4.xml · derivative · entry 4 Leimkuhler William F. · CIK 0001361943 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock · 5,000 shares Expires 2021-12-20 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: On December 12, 2017, the Reporting Person exercised his stock option to purchase 5,000 shares of the Issuer's common stock at a price of $17.33 per share F2 · balance_after: The total number of stock options owned by the Reporting Person includes options to acquire (i) 10,000 shares of Common Stock at an Exercise Price of $18.87 per share with Date Exercisable of 12/18/2013 and Expiration Date of 12/18/2022; (ii) 10,000 shares of Common Stock at an Exercise Price of $26.88 per share with Date Exercisable of 12/17/2014 and Expiration Date of 12/17/2023; (iii) 10,000 shares of Common Stock at an Exercise Price of $31.82 per share with Date Exercisable of 12/11/2015 and Expiration Date of 12/11/2024; (iv) 10,000 shares of Common Stock at an Exercise Price of $30.44 per share with Date Exercisable of 1/7/2017 and Expiration Date of 1/7/2026; and (v) 10,000 shares of common stock at a price of $71.75 per share with Date Exercisable of 1/5/2018 and Expiration Date of 1/5/2027. Read SEC document |
| December 12, 2017 Filed Dec 13, 2017 21:23 UTC | ARGAN INC AGX · Entity 3828 | Exercise / conversionCommon Stock | 5,000 | $17.33 | $86,650.00 |
DisclosureSEC source: 0001104659-17-073151 · a4.xml · nonDerivative · entry 1 Leimkuhler William F. · CIK 0001361943 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: On December 12, 2017, the Reporting Person exercised his stock option to purchase 5,000 shares of the Issuer's common stock at a price of $17.33 per share Read SEC document |
| May 25, 2017 Filed May 30, 2017 18:31 UTC | Northern Power Systems Corp. NPS · Entity 164185 | GrantCommon Shares | 30,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-036247 · doc4.xml · nonDerivative · entry 1 Leimkuhler William F. · CIK 0001361943 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 148,441 F1 · shares: Each restricted stock unit represents a contingent right to receive one share of NPS common stock. The grant represents an annual grant of restricted stock units to non-executive directors under the Northern Power Systems Corp. 2014 Stock Option and Incentive Plan. 25% of the shares vest upon grant and the remaining 75% vest in equal installments over the subsequent 3 quarters. Read SEC document |
| January 30, 2017 Filed Feb 1, 2017 00:10 UTC | ARGAN INC AGX · Entity 3828 | SaleCommon Stock | 2,000 | $73.23 | $146,459.80 |
DisclosureSEC source: 0001104659-17-005522 · a4.xml · nonDerivative · entry 4 Leimkuhler William F. · CIK 0001361943 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Simplified Employee Pension IRA Disclosed balance after: 0 F1 · shares: On January 30, 2017, the Reporting Person sold 2,000 shares of the Issuer's common stock held through his Simplified Employee Pension IRA on the open market at a price of $73.2299 per share. Read SEC document |
| January 05, 2017 Filed Feb 24, 2017 22:01 UTC | ARGAN INC AGX · Entity 3828 | GrantStock Option to purchase Common Stock · Derivative | 10,000 | $0.00 Strike: $71.75 | $0.00 |
DisclosureSEC source: 0001104659-17-011626 · a4.xml · derivative · entry 4 Leimkuhler William F. · CIK 0001361943 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,000 Underlying: Common Stock · 10,000 shares Expires 2027-01-05 F1 · shares: Pursuant to a stock option agreement dated January 5, 2017, the Reporting Person received 10-year options to purchase 10,000 shares of the Issuer's common stock with an exercise price of $71.75 per share. F2 · balance_after: The total number of stock options owned by the Reporting Person includes options to acquire (i) 5,000 shares of Common Stock at an Exercise Price of $17.33 per share with Date Exercisable of 12/20/2012 and Expiration Date of 12/20/2021; (ii) 10,000 shares of Common Stock at an Exercise Price of $18.87 per share with Date Exercisable of 12/18/2013 and Expiration Date of 12/18/2022; (iii) 10,000 shares of Common Stock at an Exercise Price of $26.88 per share with Date Exercisable of 12/17/2014 and Expiration Date of 12/17/2023; (iv) 10,000 shares of Common Stock at an Exercise Price of $31.82 per share with Date Exercisable of 12/11/2015 and Expiration Date of 12/11/2024; (v) 10,000 shares of Common Stock at an Exercise Price of $30.44 per share with Date Exercisable of 1/7/2017 and Expiration Date of 1/7/2026; and (vi) 10,000 shares of common stock at a price of $71.75 per share with Date Exercisable of 1/5/2018 and Expiration Date of 1/5/2027. Read SEC document |
| November 30, 2016 Filed Dec 2, 2016 16:07 UTC | Northern Power Systems Corp. NPS · Entity 164185 | GrantCommon Shares | 36,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-16-152988 · doc4.xml · nonDerivative · entry 1 Leimkuhler William F. · CIK 0001361943 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 118,441 F1 · shares: These shares were issued to the Reporting Person pursuant to the Northern Power Systems Corp. 2014 Stock Option and Incentive Plan in lieu of 50% of the director meeting fees. The shares are fully vested as of the grant date. Read SEC document |
| November 28, 2016 Filed Nov 28, 2016 16:12 UTC | Northern Power Systems Corp. NPS · Entity 164185 | GrantCommon Shares | 30,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-16-152175 · doc4.xml · nonDerivative · entry 1 Leimkuhler William F. · CIK 0001361943 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 82,441 F1 · shares: Annual grant of restricted common shares under the Northern Power Systems Corp. 2014 Stock Option and Incentive Plan. The shares are fully vested as of the grant date. Read SEC document |
| October 31, 2016 Filed Oct 31, 2016 20:17 UTC | ARGAN INC AGX · Entity 3828 | SaleCommon Stock | 5,000 | $56.53 | $282,650.00 |
DisclosureSEC source: 0001104659-16-153317 · a4.xml · nonDerivative · entry 1 Leimkuhler William F. · CIK 0001361943 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,000 F1 · shares: On October 31, 2016, the Reporting Person sold a total of 5,000 shares of the Issuer's common stock on the open market at an average price of $56.53 per share. Read SEC document |
| October 27, 2016 Filed Oct 28, 2016 20:36 UTC | ARGAN INC AGX · Entity 3828 | SaleCommon Stock | 4,377 | $55.47 | $242,792.19 |
DisclosureSEC source: 0001104659-16-152948 · a4.xml · nonDerivative · entry 2 Leimkuhler William F. · CIK 0001361943 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 F2 · shares: On October 27, 2016, the Reporting Person sold a total of 4,377 shares of the Issuer's common stock on the open market at an average price of $55.47 per share. As of the date of this report, the Reporting Person directly owns a total of 20,000 shares of the Issuer's common stock. Read SEC document |
| October 26, 2016 Filed Oct 28, 2016 20:36 UTC | ARGAN INC AGX · Entity 3828 | SaleCommon Stock | 623 | $55.40 | $34,514.20 |
DisclosureSEC source: 0001104659-16-152948 · a4.xml · nonDerivative · entry 1 Leimkuhler William F. · CIK 0001361943 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,377 F1 · shares: On October 26, 2016, the Reporting Person sold a total of 623 shares of the Issuer's common stock on the open market at an average price of $55.40 per share. Read SEC document |
| September 30, 2016 Filed Oct 3, 2016 20:05 UTC | ARGAN INC AGX · Entity 3828 | SaleCommon Stock | 5,000 | $59.12 | $295,600.00 |
DisclosureSEC source: 0001104659-16-148225 · a4.xml · nonDerivative · entry 1 Leimkuhler William F. · CIK 0001361943 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,000 F1 · shares: On September 30, 2016, the Reporting Person sold a total of 5,000 shares of the Issuer's common stock on the open market at a price of $59.12 per share. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.